ACD/Labs02112209462D 27 30 0 0 0 0 0 0 0 0 1 V2000 11.3912 -6.0811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.3912 -7.4111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.2393 -5.4161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.2393 -8.0761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.0876 -6.0811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.0876 -7.4111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.5430 -8.0762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.5429 -9.4063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.2393 -9.4061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.3910 -10.0712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.9357 -8.0761 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 6.7839 -7.4111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.6949 -7.4113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.8466 -8.0764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.9985 -7.4115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.1503 -8.0766 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 18.3022 -7.4118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.1502 -9.4067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 19.4539 -8.0770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.3019 -10.0718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 19.4538 -9.4070 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 20.6055 -10.0721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 21.7574 -9.4072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 20.6054 -11.4022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 22.9092 -10.0725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 21.7571 -12.0673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 22.9090 -11.4024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 1 3 2 0 0 0 0 2 4 2 0 0 0 0 3 5 1 0 0 0 0 4 6 1 0 0 0 0 5 6 2 0 0 0 0 2 7 1 0 0 0 0 7 8 1 0 0 0 0 4 9 1 0 0 0 0 8 10 1 0 0 0 0 9 10 1 0 0 0 0 6 11 1 0 0 0 0 11 12 1 0 0 0 0 7 13 1 0 0 0 0 13 14 1 0 0 0 0 14 15 1 0 0 0 0 15 16 1 0 0 0 0 16 17 1 0 0 0 0 16 18 1 0 0 0 0 17 19 1 0 0 0 0 18 20 1 0 0 0 0 19 21 1 0 0 0 0 20 21 1 0 0 0 0 21 22 1 0 0 0 0 22 23 1 0 0 0 0 22 24 1 0 0 0 0 23 25 1 0 0 0 0 24 26 1 0 0 0 0 25 27 1 0 0 0 0 26 27 1 0 0 0 0 M END > CHEBI:189648 > PB28 > A member of the class of tetralins that is tetralin that is substituted by 3-(4-cyclohexylpiperazin-1-yl)propyl and methoxy groups at positions 1 and 5, respectively. It is a sigma 2 (σ2) receptor agonist (Ki = 0.68 nM) and exhibits antineoplastic and anti SARS-CoV-2 activities. > 3 > PB-28; PB 28; 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-n-propyl]piperazine; 1-cyclohexyl-4-[3-(1,2,3,4-tetrahydro-5-methoxy-1-naphthalenyl)propyl]piperazine; 1-(3-(5-methoxytetralin-1-yl)propyl)-4-cyclohexylpiperazine > 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine > C24H38N2O > 370.581 > 370.29841 > 0 > COC1=CC=CC2=C1CCCC2CCCN1CCN(CC1)C1CCCCC1 > InChI=1S/C24H38N2O/c1-27-24-14-6-12-22-20(8-5-13-23(22)24)9-7-15-25-16-18-26(19-17-25)21-10-3-2-4-11-21/h6,12,14,20-21H,2-5,7-11,13,15-19H2,1H3 > PHRCDWVPTULQMT-UHFFFAOYSA-N > 172906-90-0 > PB-28 > 15322732; 16687172; 16891467; 18178434; 19200007; 19842660; 20021355; 20077462; 21229979; 21684636; 21744858; 22890883; 23399765; 24697311; 25637276; 28086830; 28764962; 29438891; 31994091; 33052254; 33364961; 34783163 $$$$